Mount Sinai Logo

Yumiko Kanei

  • ASSISTANT PROFESSOR Medicine, Cardiology
Print ProfilePrint Profile



  • Interventional Cardiology

  • Cardiovascular Disease

  • American Board of Internal Medicine


  • MD, Nagoya Daigaku Igakubu

  • Internship, Internal Medicine
    Beth Israel Medical Center

  • Residency, Cardiology
    Beth Israel Medical Center

  • Fellowship, Interventional Cardiology
    Beth Israel Medical Center


    Born in Nagoya, Japan.
    1998 M.D. Nagoya University School of Medicine
    1999-2002 Internal Medicine, Residency, Beth Israel Medical Center
    2004-2007 Cardiology, Fellowship, Beth Israel Medical Center
    2007-2008 Interventional Cardiology, Fellowship, Beth Israel Medical Center
    2008- Attending physician, Mount Sinai Beth Israel


  • 2012 -
    Best Teacher Award
    Beth Israel Medical Center Cardiology



Coronary artery disease
Acute myocardial infarction
Percutaneous coronary intervention
Transradial cathterization
Cardiac arrest


Kanei Y, Hanon S, Van-Tosh A, Schweitzer P. Adenosine-induced atrial fibrillation during pharmacologic stress testing: report of eight cases and review of the literature. International journal of cardiology 2008 Sep; 129(1).

Kanei Y, Friedman M, Ogawa N, Hanon S, Lam P, Schweitzer P. Frequent premature ventricular complexes originating from the right ventricular outflow tract are associated with left ventricular dysfunction. Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2008 Jan; 13(1).

Kanei Y, Huang Y, Fox JT, Rachko M, Bergmann SR. Correlation of antecedent stress myocardial perfusion imaging with the infarct related artery in ST-elevation myocardial infarction. The international journal of cardiovascular imaging 2009 Feb; 25(2).

Towatari M, Kanei Y, Saito H, Hamaguchi M. Hematopoietic transcription factor GATA-2 activates transcription from HIV-1 long terminal repeat. AIDS (London, England) 1998 Feb; 12(3).

Kanei Y, Janardhanan R, Fox JT, Gowda RM. Multivessel coronary artery thrombosis. The Journal of invasive cardiology 2009 Feb; 21(2).

Sharma J, Kanei Y, Kwan TW. A case of giant coronary artery aneurysm after placement of a heparin-coated stent. The Journal of invasive cardiology 2009 Feb; 21(2).

Ratcliffe JA, Thiagarajah P, Chen J, Kavala G, Kanei Y, Fox J, Gowda R, Schmitz SJ, Friedmann P, Bergmann S. Prevention of contrast-induced nephropathy: A randomized controlled trial of sodium bicarbonate and N-acetylcysteine. The International journal of angiology : official publication of the International College of Angiology, Inc 2009; 18(4).

Kanei Y, Sharma J, Diwan R, Sklash R, Vales LL, Fox JT, Schweitzer P. ST-segment depression in aVR as a predictor of culprit artery and infarct size in acute inferior wall ST-segment elevation myocardial infarction. Journal of electrocardiology; 43(2).

Sharma J, Roncari C, Giedd KN, Fox JT, Kanei Y. Patients with adenosine-induced ST-segment depressions and normal myocardial perfusion imaging: cardiac outcomes at 24 months. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2010 Oct; 17(5).

Kanei Y, Nakra NC, Huang Y, Fox JT. Long-term outcome of bifurcation stenting with drug-eluting stents. Angiology 2010 Oct; 61(7).

Liou M, Tung F, Kanei Y, Kwan T. Treatment of radial artery pseudoaneurysm using a novel compression device. The Journal of invasive cardiology 2010 Jun; 22(6).

Vales L, Kanei Y, Fox J. Coronary artery occlusion and myocardial infarction caused by vasospasm within a myocardial bridge. The Journal of invasive cardiology 2010 Apr; 22(4).

Shimada YJ, Nakra NC, Fox JT, Kanei Y. Relation of race (Asian, African-American, European-American, and Hispanic) to activated clotting time after weight-adjusted bolus of heparin during percutaneous coronary intervention. The American journal of cardiology 2010 Mar; 105(5).

Vales L, Kanei Y, Schweitzer P. Electrocardiographic predictors of culprit artery in acute inferior ST elevation myocardial infarction. Journal of electrocardiology; 44(1).

Kwan TW, Vales L, Liou M, Kanei Y, Chen SL. Tips and tricks for stenting of bifurcation coronary lesions. The Journal of invasive cardiology 2010 Sep; 22(9).

Vales L, Kanei Y, Ephrem G, Misra D. Intra-aortic balloon pump use and outcomes with current therapies. The Journal of invasive cardiology 2011 Mar; 23(3).

Kanei Y, Nakra NC, Liou M, Vales LL, Gowda R, Rosero H, Kwan T, Fox JT. Randomized comparison of transradial coronary angiography via right or left radial artery approaches. The American journal of cardiology 2011 Jan; 107(2).

Shimada YJ, Nakra NC, Fox JT, Kanei Y. Meta-analysis of prospective randomized controlled trials comparing intracoronary versus intravenous abciximab in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. The American journal of cardiology 2012 Mar; 109(5).

Kanei Y, Ayabe K, Ratcliffe J, Vales L, Nakra N, Friedman P, Fox J. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction. The Journal of invasive cardiology 2011 Nov; 23(11).

Kanei Y, Kwan T, Nakra NC, Liou M, Huang Y, Vales LL, Fox JT, Chen JP, Saito S. Transradial cardiac catheterization: a review of access site complications. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011 Nov; 78(6).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Kanei did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


1st Ave & 16th St
New York, NY 10003

Tel: 212-420-2416
Fax: 212-420-2406